ImageneBio (IMA) Research & Development (2020 - 2025)
ImageneBio (IMA) reported Research & Development of $15.56 million for Q3 2025, up 300.5% from $3.89 million a year earlier and up 175.2% from the prior quarter.
Powered by 
Analysis
ImageneBio (IMA) Research & Development (2020 - 2025) Analysis & Trends
Over the twelve months ended Sep 30, 2025, ImageneBio's Research & Development came in at $27.78 million, down 26.2% year-over-year; for FY2024, it came in at $30.88 million, down 48.2% from FY2023.
- Research & Development has a four-year compound annual growth rate of -8.9% (FY2020 to FY2024).
- By year, Research & Development came in at $59.65 million in FY2023 (-7.3%), $64.32 million in FY2022 (+36.5%), $47.11 million in FY2021 (+5.0%) and $44.85 million in FY2020.
- The Q3 2025 figure ranks as the highest quarterly Research & Development since Q4 2022.
- Year over year, Research & Development gained in 1 of the last eight quarters, with an average decline of 4.7%.
- The high point for year-over-year Research & Development in five years was Q3 2025 (growth of 300.5%); the low point was Q4 2024 (a decline of 82.3%).
- Per Business Quant data, the three quarters before Q3 2025 came in at $5.65 million (Q2 2025), $4.04 million (Q1 2025) and $2.53 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.81 Bn |
| 10 | ImageneBio | 34.70 Mn | -452.92 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 15.56 Mn |
| Jun 30, 2025 | 5.65 Mn |
| Mar 31, 2025 | 4.04 Mn |
| Dec 31, 2024 | 2.53 Mn |
| Sep 30, 2024 | 3.89 Mn |
| Jun 30, 2024 | 9.83 Mn |
| Mar 31, 2024 | 9.65 Mn |
| Dec 31, 2023 | 14.27 Mn |
| Sep 30, 2023 | 14.65 Mn |
| Jun 30, 2023 | 15.17 Mn |
| Mar 31, 2023 | 15.55 Mn |
| Dec 31, 2022 | 15.64 Mn |
| Sep 30, 2022 | 18.85 Mn |
| Jun 30, 2022 | 15.49 Mn |
| Mar 31, 2022 | 14.34 Mn |
| Dec 31, 2021 | 12.34 Mn |
| Sep 30, 2021 | 13.38 Mn |
| Jun 30, 2021 | 11.37 Mn |
| Mar 31, 2021 | 10.02 Mn |
| Dec 31, 2020 | 23.40 Mn |
API Access
ImageneBio Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=IMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "IMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=IMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();